Showing results (11-20 of 475) with videos related to
Sort By:
Pageof 48
Emerging Infectious Diseases|May 1, 2009
Evaluation of surveillance methods for staphylococcal toxic shock syndromeLindsey Lesher, Aaron Devries, Richard Danila, et al.Journal of the American Geriatrics Society|July 31, 2007
Antibiotic and infection tracking in Minnesota long-term care facilitiesErin O'Fallon, Jane Harper, Shelly Shaw, et al.Minnesota Medicine|September 10, 2003
Prevention of perinatal group B streptococcal disease in Minnesota: results from a retrospective cohort study and new prevention guidelinesFolashade Ogunmodede, Beth A Virnig, Richard Danila, et al.Emerging Infectious Diseases|May 1, 2013
Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010Patricia Ferrieri, Ruth Lynfield, Roberta Creti, et al.Minnesota Medicine|September 25, 2007
Toxoplasmosis prevention knowledge among pregnant women in MinnesotaFolashade Ogunmodede, Joni Scheftel, Jeffrey L Jones, et al.General Dentistry|September 7, 2018
Combating antibiotic resistance: a survey on the antibiotic-prescribing habits of dentistsSara Tomczyk, Tory Whitten, Stacy M Holzbauer, et al.The American Journal of Forensic Medicine and Pathology|August 5, 2010
Guidelines to implement medical examiner/coroner-based surveillance for fatal infectious diseases and bioterrorism ("Med-X")Kurt B Nolte, Marc Fischer, Sarah Reagan, et al.Emerging Infectious Diseases|August 21, 2015
Emerging Infections Program as Surveillance for Antimicrobial Drug ResistanceScott K Fridkin, Angela A Cleveland, Isaac See, et al.Minnesota Medicine|January 15, 2010
Novel H1N1 influenza hospitalizations: Minneapolis-St. Paul metropolitan area, 2008-2009Laura Fleege, Emily Hallberg, Craig Morin, et al.MMWR. Morbidity and Mortality Weekly Report|March 11, 2021
First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021Melanie J Firestone, Alexandra J Lorentz, Stephanie Meyer, et al.Pageof 48